J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1568.1
(-1.43%)
INR 1568.1
(-1.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 15.25 Billion INR | -43.49% |
| 2022 | 27.65 Billion INR | 77.15% |
| 2021 | 15.6 Billion INR | 21.15% |
| 2020 | 12.88 Billion INR | 18.37% |
| 2019 | 10.88 Billion INR | 10.06% |
| 2018 | 9.88 Billion INR | 20.1% |
| 2017 | 8.23 Billion INR | 8.63% |
| 2016 | 7.58 Billion INR | 16.91% |
| 2015 | 6.48 Billion INR | 13.02% |
| 2014 | 5.73 Billion INR | 13.88% |
| 2013 | 5.03 Billion INR | 25.02% |
| 2012 | 4.02 Billion INR | -8.85% |
| 2011 | 4.41 Billion INR | -22.14% |
| 2010 | 5.67 Billion INR | -23.72% |
| 2009 | 7.44 Billion INR | 4.63% |
| 2008 | 7.11 Billion INR | 28.38% |
| 2007 | 5.54 Billion INR | 5.26% |
| 2006 | 5.26 Billion INR | 11.65% |
| 2005 | 4.71 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.56 Billion INR | 24.17% |
| 2023 Q1 | 5.86 Billion INR | -53.89% |
| 2023 Q4 | 3.68 Billion INR | -35.54% |
| 2023 Q2 | 5.83 Billion INR | -0.45% |
| 2023 Q3 | 5.7 Billion INR | -2.17% |
| 2023 FY | 15.62 Billion INR | -43.49% |
| 2022 Q3 | 4.93 Billion INR | -2.79% |
| 2022 Q1 | 4.92 Billion INR | 25.74% |
| 2022 FY | 27.65 Billion INR | 77.15% |
| 2022 Q4 | 12.71 Billion INR | 157.53% |
| 2022 Q2 | 5.07 Billion INR | 3.22% |
| 2021 Q4 | 3.91 Billion INR | -0.84% |
| 2021 Q3 | 3.94 Billion INR | 2.37% |
| 2021 Q2 | 3.85 Billion INR | -1.02% |
| 2021 Q1 | 3.89 Billion INR | 38.43% |
| 2021 FY | 15.6 Billion INR | 21.15% |
| 2020 FY | 12.88 Billion INR | 18.37% |
| 2020 Q2 | 3.09 Billion INR | -7.82% |
| 2020 Q3 | 3.61 Billion INR | 16.66% |
| 2020 Q4 | 2.81 Billion INR | -22.14% |
| 2020 Q1 | 3.36 Billion INR | 39.39% |
| 2019 Q1 | 2.79 Billion INR | 41.72% |
| 2019 Q2 | 2.89 Billion INR | 3.7% |
| 2019 Q4 | 2.41 Billion INR | -13.37% |
| 2019 FY | 10.88 Billion INR | 10.06% |
| 2019 Q3 | 2.78 Billion INR | -3.94% |
| 2018 Q3 | 2.55 Billion INR | -7.32% |
| 2018 Q2 | 2.75 Billion INR | 17.69% |
| 2018 Q1 | 2.34 Billion INR | 0.0% |
| 2018 FY | 9.88 Billion INR | 20.1% |
| 2018 Q4 | 1.97 Billion INR | -22.89% |
| 2017 Q1 | 1.72 Billion INR | -10.56% |
| 2017 FY | 8.23 Billion INR | 8.63% |
| 2016 FY | 7.58 Billion INR | 16.91% |
| 2016 Q4 | 1.93 Billion INR | 0.0% |
| 2015 FY | 6.48 Billion INR | 13.02% |
| 2015 Q4 | 1.91 Billion INR | 0.0% |
| 2014 FY | 5.73 Billion INR | 13.88% |
| 2013 Q1 | 1.3 Billion INR | 0.0% |
| 2013 FY | 5.03 Billion INR | 25.02% |
| 2012 Q1 | 1.06 Billion INR | 0.0% |
| 2012 FY | 4.02 Billion INR | -8.85% |
| 2011 FY | 4.41 Billion INR | -22.14% |
| 2010 FY | 5.67 Billion INR | -23.72% |
| 2009 FY | 7.44 Billion INR | 4.63% |
| 2008 FY | 7.11 Billion INR | 28.38% |
| 2007 FY | 5.54 Billion INR | 5.26% |
| 2006 FY | 5.26 Billion INR | 11.65% |
| 2005 FY | 4.71 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -13399.996% |
| Aarti Drugs Limited | 8.31 Billion INR | -83.484% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -161.67% |
| Ajanta Pharma Limited | 21.06 Billion INR | 27.559% |
| Alembic Limited | 1 Billion INR | -1425.728% |
| Alkem Laboratories Limited | 52.29 Billion INR | 70.823% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 43.023% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -145.214% |
| Bal Pharma Limited | 770.19 Million INR | -1881.175% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -121533.4% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -312.912% |
| Brooks Laboratories Limited | 65.62 Million INR | -23153.444% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -3274.723% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -65.741% |
| Divi's Laboratories Limited | 32.44 Billion INR | 52.963% |
| Eris Lifesciences Limited | 10.42 Billion INR | -46.343% |
| Granules India Limited | 16.79 Billion INR | 9.169% |
| Ind-Swift Limited | 2.17 Billion INR | -602.356% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2238.208% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 22.319% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -2359.223% |
| Medicamen Biotech Limited | 495.49 Million INR | -2979.529% |
| Medico Remedies Limited | 262.14 Million INR | -5720.812% |
| Wockhardt Limited | 7.72 Billion INR | -97.654% |
| Orchid Pharma Limited | 2.32 Billion INR | -557.626% |
| RPG Life Sciences Limited | 2.48 Billion INR | -514.535% |
| Shilpa Medicare Limited | 3.56 Billion INR | -328.393% |
| Sigachi Industries Limited | 2 Billion INR | -662.076% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 1021.487% |
| Unichem Laboratories Limited | 4.86 Billion INR | -213.651% |
| Vaishali Pharma Limited | 90.32 Million INR | -16793.715% |
| Wanbury Limited | 1.73 Billion INR | -781.69% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 87.813% |
| FDC Limited | 6.58 Billion INR | -131.68% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -628.684% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -936.747% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 90.673% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -22.729% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -269.178% |
| Laurus Labs Limited | 15.44 Billion INR | 1.229% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -2107.619% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -216.359% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -2783.741% |
| Hester Biosciences Limited | 1.27 Billion INR | -1098.046% |
| Ipca Laboratories Limited | 48.58 Billion INR | 68.593% |
| Venus Remedies Limited | 2.18 Billion INR | -599.121% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1103.562% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 86.07% |
| Morepen Laboratories Limited | 6.16 Billion INR | -147.658% |
| Neuland Laboratories Limited | 8.24 Billion INR | -85.005% |
| Sequent Scientific Limited | 2.97 Billion INR | -412.262% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -270.068% |
| Valiant Laboratories Limited | 138.02 Million INR | -10954.858% |
| Windlas Biotech Limited | 1.33 Billion INR | -1039.745% |
| Hikal Limited | 5.95 Billion INR | -156.108% |
| Innova Captab Limited | 3.46 Billion INR | -340.444% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -163.931% |
| Themis Medicare Limited | 2.42 Billion INR | -530.532% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -223.344% |
| Mankind Pharma Limited | 42.19 Billion INR | 63.839% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 77.994% |
| Sakar Healthcare Limited | 699.58 Million INR | -2081.137% |
| Albert David Limited | 1.4 Billion INR | -983.662% |
| Lupin Limited | 125.09 Billion INR | 87.802% |
| Gufic Biosciences Limited | 4.07 Billion INR | -274.568% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 94.097% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -708.691% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -2627.226% |
| Piramal Enterprises Limited | 8.04 Billion INR | -89.71% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 67.366% |
| NATCO Pharma Limited | 25.73 Billion INR | 40.71% |
| Suven Life Sciences Limited | -200.79 Million INR | 7699.172% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 14131.569% |
| Strides Pharma Science Limited | 14.38 Billion INR | -6.052% |
| Indoco Remedies Limited | 8.04 Billion INR | -89.717% |
| Alpa Laboratories Limited | 188.89 Million INR | -7977.985% |
| Lasa Supergenerics Limited | 121.02 Million INR | -12507.544% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -3801.876% |